Electron- and Positron-Emitting Radiolanthanides for Therapy: Aspects of Dosimetry and Production
Helena Uusijärvi1,
Peter Bernhardt1,
Frank Rösch2,
Helmut R. Maecke3 and
Eva Forssell-Aronsson1
1 Department of Radiation Physics, Göteborg University, Sahlgrenska University Hospital, Göteborg, Sweden; 2 Institute for Nuclear Chemistry, Johannes Gutenberg-University Mainz, Mainz, Germany; and 3 Division of Radiological Chemistry, University Hospital Basel, Basel, Switzerland

View larger version (20K):
[in a new window]
|
FIGURE 1. TN divided by TNC as function of tumor size for electron-emitting radiolanthanide 177Lu.
|
|

View larger version (44K):
[in a new window]
|
FIGURE 2. TN as function of tumor size for electron-emitting radiolanthanides. In all panels, 177Lu, 90Y, and 131I are shown for comparison.
|
|

View larger version (19K):
[in a new window]
|
FIGURE 3. TN as function of tumor size for positron-emitting radiolanthanides. Corresponding values for 90Y and 131I are shown for comparison.
|
|
Copyright © 2006 by the Society of Nuclear Medicine.